Genetic deletion of MIF or inhibition of its nuclease activity in cancer cells significantly increases mutation frequency, reduces DNA synthesis, causes cell cycle delay, inhibits colony survival, and attenuates the growth of breast tumors, glioblastoma, and colon tumors in mice. Here, MIF is linked to cancer.